Cargando…
Identification of STAT5B as a biomarker associated with prognosis and immune infiltration in breast cancer
Breast invasive cancer (BRCA) is the most common malignancy and the second leading cause of malignancy death among women. Signal transducers and activators of transcription (STAT) family played a vital role in regulating certain biological processes and could serve as biomarkers for many diseases or...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981440/ https://www.ncbi.nlm.nih.gov/pubmed/36862902 http://dx.doi.org/10.1097/MD.0000000000032972 |
_version_ | 1784900103465598976 |
---|---|
author | Li, Jiaying Li, Li Mahesutihan, Gulijiang Meng, Juanjuan Chen, Yuan Lv, Jingsen |
author_facet | Li, Jiaying Li, Li Mahesutihan, Gulijiang Meng, Juanjuan Chen, Yuan Lv, Jingsen |
author_sort | Li, Jiaying |
collection | PubMed |
description | Breast invasive cancer (BRCA) is the most common malignancy and the second leading cause of malignancy death among women. Signal transducers and activators of transcription (STAT) family played a vital role in regulating certain biological processes and could serve as biomarkers for many diseases or cancers. METHODS: The expression, prognostic value, and clinical functions of STAT family in BRCA were evaluated with several bioinformatics web portals. RESULTS: The expression of STAT5A/5B were downregulated in BRCA in subgroup analyses based on race, age, gender, race, subclasses, tumor histology, menopause status, nodal metastasis status, and TP53 mutation. BRCA patients with high STAT5B expression had a better overall survival, relapse free survival, MDFS and post progression survival. STAT5B expression level can impact the prognosis in BRCA patients with positive PR status, negative Her2 status and wild type TP53. Moreover, STAT5B was positively correlated with immune cell infiltration and the level of immune biomarkers. Drug sensitivity revealed that low STAT5B expression was resistant to the many small molecules or drugs. Functional enrichment analysis revealed that STAT5B was involved in adaptive immune response, translational initiation, JAK-STAT signaling pathway, Ribosome, NF-kappa B signaling pathway and Cell adhesion molecules. CONCLUSIONS: STAT5B was a biomarker associated with prognosis and immune infiltration in breast cancer. |
format | Online Article Text |
id | pubmed-9981440 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-99814402023-03-04 Identification of STAT5B as a biomarker associated with prognosis and immune infiltration in breast cancer Li, Jiaying Li, Li Mahesutihan, Gulijiang Meng, Juanjuan Chen, Yuan Lv, Jingsen Medicine (Baltimore) 5700 Breast invasive cancer (BRCA) is the most common malignancy and the second leading cause of malignancy death among women. Signal transducers and activators of transcription (STAT) family played a vital role in regulating certain biological processes and could serve as biomarkers for many diseases or cancers. METHODS: The expression, prognostic value, and clinical functions of STAT family in BRCA were evaluated with several bioinformatics web portals. RESULTS: The expression of STAT5A/5B were downregulated in BRCA in subgroup analyses based on race, age, gender, race, subclasses, tumor histology, menopause status, nodal metastasis status, and TP53 mutation. BRCA patients with high STAT5B expression had a better overall survival, relapse free survival, MDFS and post progression survival. STAT5B expression level can impact the prognosis in BRCA patients with positive PR status, negative Her2 status and wild type TP53. Moreover, STAT5B was positively correlated with immune cell infiltration and the level of immune biomarkers. Drug sensitivity revealed that low STAT5B expression was resistant to the many small molecules or drugs. Functional enrichment analysis revealed that STAT5B was involved in adaptive immune response, translational initiation, JAK-STAT signaling pathway, Ribosome, NF-kappa B signaling pathway and Cell adhesion molecules. CONCLUSIONS: STAT5B was a biomarker associated with prognosis and immune infiltration in breast cancer. Lippincott Williams & Wilkins 2023-03-03 /pmc/articles/PMC9981440/ /pubmed/36862902 http://dx.doi.org/10.1097/MD.0000000000032972 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | 5700 Li, Jiaying Li, Li Mahesutihan, Gulijiang Meng, Juanjuan Chen, Yuan Lv, Jingsen Identification of STAT5B as a biomarker associated with prognosis and immune infiltration in breast cancer |
title | Identification of STAT5B as a biomarker associated with prognosis and immune infiltration in breast cancer |
title_full | Identification of STAT5B as a biomarker associated with prognosis and immune infiltration in breast cancer |
title_fullStr | Identification of STAT5B as a biomarker associated with prognosis and immune infiltration in breast cancer |
title_full_unstemmed | Identification of STAT5B as a biomarker associated with prognosis and immune infiltration in breast cancer |
title_short | Identification of STAT5B as a biomarker associated with prognosis and immune infiltration in breast cancer |
title_sort | identification of stat5b as a biomarker associated with prognosis and immune infiltration in breast cancer |
topic | 5700 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981440/ https://www.ncbi.nlm.nih.gov/pubmed/36862902 http://dx.doi.org/10.1097/MD.0000000000032972 |
work_keys_str_mv | AT lijiaying identificationofstat5basabiomarkerassociatedwithprognosisandimmuneinfiltrationinbreastcancer AT lili identificationofstat5basabiomarkerassociatedwithprognosisandimmuneinfiltrationinbreastcancer AT mahesutihangulijiang identificationofstat5basabiomarkerassociatedwithprognosisandimmuneinfiltrationinbreastcancer AT mengjuanjuan identificationofstat5basabiomarkerassociatedwithprognosisandimmuneinfiltrationinbreastcancer AT chenyuan identificationofstat5basabiomarkerassociatedwithprognosisandimmuneinfiltrationinbreastcancer AT lvjingsen identificationofstat5basabiomarkerassociatedwithprognosisandimmuneinfiltrationinbreastcancer |